Searched for
PFIZER MARKET UPDATE
Trump unveils 100% tariff on some patented drugs on 'Liberation Day' anniversaryPresident Donald Trump has signed an executive order introducing significant pharmaceutical tariffs. Companies failing to strike pricing de...- US stock market today: Dow, S&P 500, Nasdaq Pull Back from record highs as Gold hits fresh all-time peakUS stocks fell slightly as investors waited for Fed speeches and key inflation data. Gold hit a record high while Bitcoin and other cryptoc...
- FDA issues new heart risk warnings for Pfizer, Moderna COVID vaccines - should you be worried?The FDA has issued warnings regarding potential cardiac risks, specifically myocarditis and pericarditis, associated with the Pfizer and Mo...
- Novavax awaits FDA decision on whether its next COVID shot can be offered in USNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator tol...
- Pfizer shares sink after it resets 2024 Covid expectationsRevenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...
- Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayModerna, the COVID-19 vaccine manufacturer, is poised to meet its 2023 sales target as it taps into the private market. Analysts suggest th...
- Covid 19 vaccines' updated versions to be available in US market in September, say CDC, FDA officials. Check age limit, where to getCovid-19 vaccines' updated versions will be available in the US by mid-September and will be distributed through the commercial market, CDC...
- Pfizer rallies 8% on strong Q2 show, new Covid pillThe US multinational pharmaceutical and biotechnology firm further announced that its experimental antiviral pill to treat COVID-19 can cut...
- Moderna working on booster to combine COVID-19 vaccine with a flu shotFlu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...
- Pfizer COVID-19 shot 91% effective in updated data, protective against South African variantThe shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is domina...
- Govt panel recommends marketing authorisation to Serum Institute’s Covishield vaccine"The Subject Expert Committee has recommended in favour of marketing authoritsation to SII’s vaccine but with certain conditions, a person ...
- Serum's chances for Covishield nod rise after UK regulator approves Oxford COVID-19 vaccineThe SEC was called soon after the UK regulator authorised Oxford University/AstraZeneca’s Covid-19 vaccine for use. The approval by UK regu...
- Nikkei slips from multi-decade highs on vaccine supply concernsThe Nikkei share average fell 0.22% to 26,751.24, but posted its fifth consecutive weekly gain. In the previous session, the index settled ...
- Market Movers: Diagnostic firms tank; MACD shows RIL, IRCTC set to rallyShares of Pfizer hit an all-time high of Rs 5,875 after the company said that its vaccine data suggests the shots maybe 90 per cent effecti...
- Stock market update: 13 stocks hit 52-week highs on NSEAmong the stocks that touched their 52-week highs were Pfizer and Deepak Nitrite.
- Share market update: Pfizer, Artemis Medicare among top gainers on BSEAmong the 50 components in the Nifty index, 48 shares were trading in the green, while 2 were in the red.
- Pfizer surges 5% as Q3 net profit rise over two-foldShares of Pfizer India, world's premier biopharmaceutical firm, surged over 5 per cent in Thursday's trade after the company reported a two...
- Biocon has substantial upsides: Rajesh Jain"Amongst the Indian tier 2 pharma companies, Biocon is certainly a pick."
- Pfizer shifts focus to cancer and biotech drugsPfizer Inc. is shifting its research focus to diseases that have high potential for big profits and for treatment improvements, such as can...
- Pfizer warns of lung cancer link with inhaled insulinUS drugmakers Pfizer Inc and Nektar Therapeutics warned of cases of lung cancer in clinical trials of their inhaled insulin Exubera.
Load More
